These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 219278

  • 21. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease.
    Schram AW, Hamers MN, Oldenbroek-Haverkamp E, Strijland A, de Jonge A, van den Bergh FA, Tager JM.
    Biochim Biophys Acta; 1978 Dec 08; 527(2):456-64. PubMed ID: 31916
    [Abstract] [Full Text] [Related]

  • 22. [Alpha-galactosidase A deficiency--Fabry's disease].
    Tsuji S.
    Tanpakushitsu Kakusan Koso; 1988 Apr 08; 33(5):745-8. PubMed ID: 2855953
    [No Abstract] [Full Text] [Related]

  • 23. [Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase].
    Selgas R, García de Lorenzo A, Valdés F, Beck M.
    Nefrologia; 2001 Apr 08; 21(5):443-7. PubMed ID: 11795012
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Alpha-galactosidases and alpha-N-acetylgalactosaminidase. Biochemical bases of Fabry's disease].
    Salvayre R, Negre A, Maret A, Douste-Blazy L.
    Pathol Biol (Paris); 1984 Apr 08; 32(4):269-84. PubMed ID: 6326022
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The properties of alpha-galactosidase remaining in kidney and liver of patients with Fabry's disease.
    Kano I, Yamakawa T.
    Chem Phys Lipids; 1974 Dec 08; 13(4):283-91. PubMed ID: 4217662
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. New therapies for Fabry's disease.
    Gahl WA.
    N Engl J Med; 2001 Jul 05; 345(1):55-7. PubMed ID: 11439950
    [No Abstract] [Full Text] [Related]

  • 36. [Fabry's disease: kidney insufficiency in heterozygous patient].
    Pravatà G, Pinto G, Noto G, Aricò M.
    G Ital Dermatol Venereol; 1989 Jul 05; 124(11-12):505-9. PubMed ID: 2561653
    [Abstract] [Full Text] [Related]

  • 37. A case of Fabry's disease in a patient with no alpha-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser.
    Koide T, Ishiura M, Iwai K, Inoue M, Kaneda Y, Okada Y, Uchida T.
    FEBS Lett; 1990 Jan 01; 259(2):353-6. PubMed ID: 2152885
    [Abstract] [Full Text] [Related]

  • 38. A microtechnique for quantitative measurements of acid hydrolases in fibroblasts. Its application in diagnosis of Fabry disease and enzyme replacement studies.
    Hasholt L, Sørensen SA.
    Clin Chim Acta; 1984 Sep 29; 142(2):257-61. PubMed ID: 6094040
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.